Celldex Therapeutics, Inc. Business Combination, Contingent Consideration, Liability
Celldex Therapeutics, Inc. (CLDX) had Business Combination, Contingent Consideration, Liability of $6.33 million as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2023-02-28
- 2022-03-31: Business Combination, Contingent Consideration, Liability $6.33M.
- 2021-12-31: Business Combination, Contingent Consideration, Liability $6.86M.
- 2021-09-30: Business Combination, Contingent Consideration, Liability $7.11M.
- 2021-06-30: Business Combination, Contingent Consideration, Liability $9.01M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2022-03-31 | $6.33M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.86M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.11M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $9.01M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.75M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.27M 10-K · filed 2022-02-28 |
| 2020-09-30 | $8.25M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $12.72M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $12.48M 10-K · filed 2021-03-29 |
| 2019-09-30 | $12.17M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.28M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $15.30M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $13.78M 10-K · filed 2020-03-26 |
| 2018-09-30 | $15.43M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $22.37M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $29.80M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $43.40M 10-K · filed 2019-03-07 |
| 2017-09-30 | $44.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $48.60M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $47.60M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $44.20M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |